Publications by authors named "Mathieu Ferrari"

Claim this Profile
P
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia.
Nicola Maciocia, Malika Hoekx, Ciaran Acuna, Brandon Wade, Amy Burley, Mathieu Ferrari

Sci Transl Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.
Kate Cwynarski, Gloria Iacoboni, Eleni Tholouli, Tobias Menne, David A Irvine, Mathieu Ferrari

Nat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Situ Tracking of TCRβ Isoforms for Detection of T Cell Clonality: Implication for Precision Diagnosis and Targeted Immunotherapy of T-Cell Neoplasms.
Marie Therese Manipadam, Andrea Marra, Alan Ramsay, Sugerdana Padmasri, Adheesh Gosh, Mathieu Ferrari

Hematol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies.
Mathieu Ferrari, Farhaan Parekh, Paul Maciocia, Pedro Horna, Simon Thomas

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.
Evangelia Kokalaki, Biao Ma, Mathieu Ferrari, Thomas Grothier, Warren Hazelton

Mol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein-Protein Interaction.
Ram Jha, Alexander Kinna, Alastair Hotblack, Reyisa Bughda, Anna Bulek, Mathieu Ferrari

ACS Chem Biol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.
Mathieu Ferrari, Matteo Righi, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry.
Pedro Horna, Matthew J Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng

Blood Cancer J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.
Evangelia Kokalaki, Biao Ma, Mathieu Ferrari, Thomas Grothier, Warren Hazelton

Mol Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2.
Julia Taylor, Anna Bulek, Isaac Gannon, Mathew Robson, Evangelia Kokalaki, Mathieu Ferrari

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy.
Lydia Lee, Wen Chean Lim, Daria Galas-Filipowicz, Kent Fung, Julia Taylor, Mathieu Ferrari

J Immunother Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments.
Francesco Nannini, Lenart Senicar, Farhaan Parekh, Khai J Kong, Alexander Kinna, Mathieu Ferrari

MAbs· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency.
Adam Leach, F Tudor Ilca, Zulaikha Akbar, Mathieu Ferrari, Emma M Bentley

Antiviral Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial.
Shaun Cordoba, Shimobi Onuoha, Simon Thomas, Daniela Soriano Pignataro, Rachael Hough, Mathieu Ferrari

Nat Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis.
Mathieu Ferrari, Shimobi C Onuoha, Liliane Fossati-Jimack, Alessandra Nerviani, Pedro L Alves

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants.
Mathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, Zulaikha Akbar, Reyisa Bughda

J Virol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike.
Leila Mekkaoui, Emma M Bentley, Mathieu Ferrari, Katarina Lamb, Katarzyna Ward

Bio Protoc· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats.
Francesco Nannini, Farhaan Parekh, Patrycja Wawrzyniecka, Leila Mekkaoui, Matteo Righi, Mathieu Ferrari

Sci Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.
Sara Ghorashian, Anne Marijn Kramer, Shimobi Onuoha, Gary Wright, Jack Bartram, Mathieu Ferrari

Nat Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Going with the flow: harnessing the power of the vasculature for targeted therapy in rheumatoid arthritis.
Mathieu Ferrari, Shimobi C Onuoha, Costantino Pitzalis

Drug Discov Today· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design of antirheumatic prodrugs specific for sites of inflammation.
Shimobi C Onuoha, Mathieu Ferrari, Daniele Sblattero, Costantino Pitzalis

Arthritis Rheumatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trojan horses and guided missiles: targeted therapies in the war on arthritis.
Mathieu Ferrari, Shimobi C Onuoha, Costantino Pitzalis

Nat Rev Rheumatol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IκB kinase ε targets interferon regulatory factor 1 in activated T lymphocytes.
Marco Sgarbanti, Giulia Marsili, Anna Lisa Remoli, Emilia Stellacci, Antonello Mai, Mathieu Ferrari

Mol Cell Biol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis.
Panagiotis Kamperidis, Tahereh Kamalati, Mathieu Ferrari, Margaret Jones, Toby Garrood

Arthritis Rheum· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis